176 related articles for article (PubMed ID: 17336111)
1. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53.
Morris JS; Nixon C; Bruck A; Nasir L; Morgan IM; Philbey AW
Vet J; 2008 Feb; 175(2):218-26. PubMed ID: 17336111
[TBL] [Abstract][Full Text] [Related]
2. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches.
Rodo A; Malicka E
Pol J Vet Sci; 2008; 11(2):89-95. PubMed ID: 18683536
[TBL] [Abstract][Full Text] [Related]
4. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study.
Dias Pereira P; Carvalheira J; Gärtner F
Vet J; 2004 Sep; 168(2):180-5. PubMed ID: 15301767
[TBL] [Abstract][Full Text] [Related]
5. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
6. An Immunohistochemical study of HER-2 expression in feline mammary tumours.
Rasotto R; Caliari D; Castagnaro M; Zanetti R; Zappulli V
J Comp Pathol; 2011; 144(2-3):170-9. PubMed ID: 20880546
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evaluation of STAT3-p-tyr705 expression in feline mammary gland tumours and correlation with histologic grade.
Petterino C; Ratto A; Podestà G; Drigo M; Pellegrino C
Res Vet Sci; 2007 Apr; 82(2):218-24. PubMed ID: 16934302
[TBL] [Abstract][Full Text] [Related]
8. Tumor morphology and immunohistochemical expression of estrogen receptor, progesterone receptor, p53, and Ki67 in urogenital carcinomas of California sea lions (Zalophus californianus).
Colegrove KM; Gulland FM; Naydan DK; Lowenstine LJ
Vet Pathol; 2009 Jul; 46(4):642-55. PubMed ID: 19276047
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of feline COX-2 and expression in feline mammary carcinomas.
Sayasith K; Sirois J; Doré M
Vet Pathol; 2009 May; 46(3):423-9. PubMed ID: 19176489
[TBL] [Abstract][Full Text] [Related]
10. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
[TBL] [Abstract][Full Text] [Related]
11. Expression of NOS and VEGF in feline mammary tumours and their correlation with angiogenesis.
Islam MS; Matsumoto M; Hidaka R; Miyoshi N; Yasuda N
Vet J; 2012 Jun; 192(3):338-44. PubMed ID: 22154426
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of p63 and deltaNp63 in mixed tumors of canine mammary glands and its relation with p53 expression.
Bertagnolli AC; Cassali GD; Genelhu MC; Costa FA; Oliveira JF; Gonçalves PB
Vet Pathol; 2009 May; 46(3):407-15. PubMed ID: 19176510
[TBL] [Abstract][Full Text] [Related]
14. Mammary mucinous carcinoma in the cat.
Sarli G; Brunetti B; Benazzi C
Vet Pathol; 2006 Sep; 43(5):667-73. PubMed ID: 16966443
[TBL] [Abstract][Full Text] [Related]
15. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis.
Ferrari A; Petterino C; Ratto A; Campanella C; Wurth R; Thellung S; Vito G; Barbieri F; Florio T
BMC Vet Res; 2012 Mar; 8():27. PubMed ID: 22417013
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of p53, fibroblast growth factor-b, and transforming growth factor-alpha in feline vaccine-associated sarcomas.
Nieto A; Sánchez MA; Martínez E; Rollán E
Vet Pathol; 2003 Nov; 40(6):651-8. PubMed ID: 14608018
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential.
Millanta F; Calandrella M; Citi S; Della Santa D; Poli A
Vet Pathol; 2005 Jan; 42(1):30-4. PubMed ID: 15657269
[TBL] [Abstract][Full Text] [Related]
19. Aberrant p53 expression in feline vaccine-associated sarcomas and correlation with prognosis.
Hershey AE; Dubielzig RR; Padilla ML; Helfand SC
Vet Pathol; 2005 Nov; 42(6):805-11. PubMed ID: 16301577
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
